James C. Garbutt

Psychiatry

101 Manning Dr
Chapel Hill, NC 27514

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Risk and resilience for alcohol use disorder revealed in brain functional connectivity.

Risk and resilience for alcohol use disorder revealed in brain functional connectivity.

Journal: NeuroImage. Clinical

Published: May 05, 2021

Exploration of the Impact of Combining Risk Phenotypes on the Likelihood of Alcohol Problems in Young Adults.

Exploration of the Impact of Combining Risk Phenotypes on the Likelihood of Alcohol Problems in Young Adults.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire)

Published: May 04, 2021

Efficacy and tolerability of baclofen in a U.S. community population with alcohol use disorder: a dose-response, randomized, controlled trial.

Efficacy and tolerability of baclofen in a U.S. community population with alcohol use disorder: a dose-response, randomized, controlled trial.

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Published: November 23, 2020

The melanocortin system as a potential target for treating alcohol use disorders: A review of pre-clinical data.

The melanocortin system as a potential target for treating alcohol use disorders: A review of pre-clinical data.

Journal: Brain research

Published: September 11, 2019

Approval of Baclofen for Alcohol Use Disorders in France: A Perspective From the United States.

Approval of Baclofen for Alcohol Use Disorders in France: A Perspective From the United States.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire)

Published: July 03, 2019

A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection.

A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection.

Journal: Hepatology (Baltimore, Md.)

Published: June 21, 2019

A Preliminary, Open-Label Study of Naltrexone and Bupropion Combination Therapy for Treating Binge Drinking in Human Subjects.

A Preliminary, Open-Label Study of Naltrexone and Bupropion Combination Therapy for Treating Binge Drinking in Human Subjects.

Journal: Alcohol and alcoholism (Oxford, Oxfordshire)

Published: June 09, 2019

Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice.

Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice.

Journal: Alcoholism, clinical and experimental research

Published: January 03, 2019

The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective.

The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective.

Journal: Frontiers in psychiatry

Published: October 05, 2018

Baclofen for the treatment of alcohol use disorder: the Cagliari Statement.

Baclofen for the treatment of alcohol use disorder: the Cagliari Statement.

Journal: The lancet. Psychiatry

Published: July 17, 2018

Use of Baclofen for Alcohol Use Disorders in the United States.

Use of Baclofen for Alcohol Use Disorders in the United States.

Journal: Frontiers in psychiatry

Published: July 09, 2018

Implementation of a Process for Initiating Naltrexone in Patients Hospitalized for Alcohol Detoxification or Withdrawal.

Implementation of a Process for Initiating Naltrexone in Patients Hospitalized for Alcohol Detoxification or Withdrawal.

Journal: Journal of hospital medicine

Published: January 25, 2018

Showing 1-12 of 29

Last Updated: 09/26/2026